Given that chemotactic GPCRs are well-recognized promoters of tumor growth and dissemination (1, 3, 6, 63, 77), our findings place ARHGEF17 within the repertoire of relevant signaling effectors in oncogenic settings. The gene discussed is ARHGEF17; the disease is neoplasm.